NEW YORK, April 4, 2014 /PRNewswire/ --
Today, Analysts Review released its analysts' notes regarding
The Dow Chemical Company (NYSE: DOW), Cameco Corp. (NYSE: CCJ),
Ultra Petroleum Corp. (NYSE: UPL), AngloGold Ashanti Ltd. (NYSE:
AU), and Amyris, Inc. (NASDAQ: AMRS). Private wealth members
receive these notes ahead of publication. To reserve complementary
membership, limited openings are available at:
http://www.AnalystsReview.com/register
The Dow Chemical Company Analyst Notes
On March 31, 2014, The Dow
Chemical Company (Dow) announced the successful start-up of its
joint venture facility membrane chlor-alkali facility with Mitsui
& Co., Ltd. of Tokyo, Japan
(Mitsui). According to the Company, its share of the chlorine
produced at the Dow-Mitsui Chlor-Alkali Freeport, Texas, facility will meet the
feedstock needs of the Company's performance- and market-driven
businesses. Dow added that it will also market the caustic soda on
behalf of the joint venture. Dow Executive Vice President
James R. Fitterling commented, "This
world-class facility allows us to capitalize on our modern and
efficient membrane chlor-alkali technology and serves as a
real-life proof point of how new, competitive energy resources in
the U.S. are re-shaping the landscape of U.S. Gulf Coast
manufacturing. This joint venture bolsters the integration strength
of the chlorine value chain at the Freeport site in a capital efficient model
that allows Dow to invest in more downstream technology and
customer-driven businesses with higher and more consistent
earnings." The full analyst notes on The Dow Chemical Company are
available to download free of charge at:
http://www.AnalystsReview.com/04042014/DOW/report.pdf
Cameco Corp. Analyst Notes
On March 31, 2014, Cameco Corp.
(Cameco) announced that effective December
31, 2014 its toll-conversion agreement with Springfields
Fuels Ltd. (SFL) will be terminated. According to the Company, it
signed a 10-year toll-conversion agreement with SFL in 2005 to
process up to 5 million kilograms of uranium every year at the
Springfields conversion facility in Lancashire, United Kingdom. The Company stated
that it settled to pay $18 million to
SFL to end the agreement, which was set to expire in 2016. In
addition, the Company mentioned that its production at the
Springfields facility will end by August 31,
2014. Tim Gitzel, President
and CEO of Cameco, said, "With the current weak market for
UF6 conversion we can meet our customer requirements
from our Port Hope conversion facility and benefit from better
utilization of existing assets." The full analyst notes on Cameco
Corp. are available to download free of charge at:
http://www.AnalystsReview.com/04042014/CCJ/report.pdf
Ultra Petroleum Corp. Analyst Notes
On April 1, 2014, Ultra Petroleum
Corp. (Ultra) announced William
Picquet's intention to retire as Senior Vice President of
Operations. Ultra added that he will serve in a non-executive
advisory capacity until his effective retirement date of
April 30, 2014. The Company further
announced that its Board of Directors has promoted Brad Johnson to the position of Senior Vice
President, Operations, effective April 1,
2014. Commenting on Mr. Picquet's retirement, Michael D. Watford, Ultra's Chairman, President
and CEO, stated, "We are grateful for Bill's leadership and wisdom
he displayed each and every day. He has left an indelible mark on
all of us and we will miss him. Having known Bill for almost 25
years, I want to personally thank him for his loyalty and dedicated
service to Ultra and wish him well in his retirement." The full
analyst notes on Ultra Petroleum Corp. are available to download
free of charge at:
http://www.AnalystsReview.com/04042014/UPL/report.pdf
AngloGold Ashanti Ltd. Analyst Notes
On March 25, 2014, AngloGold
Ashanti Ltd. (AngloGold Ashanti) announced the appointment of
David L. Hodgson to its board of
directors. According to the Company, Mr. Hodgson will be an
independent non-executive director, effective April 25, 2014. AngloGold Ashanti mentioned that
Mr. Hodgson previously served as the Company's Chief Operating
Officer from November 2001 to
April 2005, after which he retired.
In addition, the Company said that Mr. Hodgson also served
Anglo American and De Beers group of
companies for three decades in a series of senior and executive
positions. AngloGold Ashanti's Chairman of the Board of Directors,
commented, "I'm delighted to welcome Mr Hodgson to the Board. His
depth of operating and board experience will be a tremendous asset
to our business." The full analyst notes on AngloGold Ashanti Ltd.
are available to download free of charge at:
http://www.AnalystsReview.com/04042014/AU/report.pdf
Amyris, Inc. Analyst Notes
On March 31, 2014, Amyris, Inc.
(Amyris) announced the expansion and extension of its ongoing
collaboration with Kuraray Co., Ltd. (Kuraray) in high performance
polymers using Amyris' Biofene® brand of renewable farnesene. The
Company stated that according to the transaction agreements, the
duration of research and development portion of the collaboration
between the Companies will be extended for at least two more years.
In addition, the Company said that over the next two years, it will
receive an undisclosed amount of collaboration funding, and
approximately $4 million worth of
Amyris' common stock will be purchased by Kuraray in April 2014. The full analyst notes on Amyris,
Inc. are available to download free of charge at:
http://www.AnalystsReview.com/04042014/AMRS/report.pdf
About Analysts Review
We provide our members with a simple and reliable way to leverage
our economy of scale. Most investors do not have time to track all
publicly traded companies, much less perform an in-depth review and
analysis of the complexities contained in each situation. That's
where Analysts Review comes in. We provide a single unified
platform for investors' to hear about what matters. Situation
alerts, moving events, and upcoming opportunities.
=============
EDITOR NOTES:
- This is not company news. We are an independent source and our
views do not reflect the companies mentioned.
- Information in this release is fact checked and produced on a
best efforts basis and reviewed by Nidhi Vatsal, a CFA
charterholder. However, we are only human and are prone to make
mistakes. If you notice any errors or omissions, please notify us
below.
- This information is submitted as a net-positive to companies
mentioned, to increase awareness for mentioned companies to our
subscriber base and the investing public.
- If you wish to have your company covered in more detail by our
team, or wish to learn more about our services, please contact us
at pubco [at] AnalystsReview.com.
- For any urgent concerns or inquiries, please contact us
at compliance [at] AnalystsReview.com.
- Are you a public company? Would you like to see similar
coverage on your company? Send us a full investors' package to
research [at] AnalystsReview.com for consideration.
COMPLIANCE PROCEDURE
Content is researched, written and reviewed on a best-effort
basis. This document, article or report is prepared and authored by
Analysts Review. An outsourced research services provider
represented by Nidhi Vatsal, CFA, has only reviewed the information
provided by Analysts Review in this article or report according to
the Procedures outlined by Analysts Review. Analysts Review is not
entitled to veto or interfere in the application of such procedures
by the outsourced provider to the articles, documents or reports,
as the case may be.
NOT FINANCIAL ADVICE
Analysts Review makes no warranty, expressed or implied, as to
the accuracy or completeness or fitness for a purpose (investment
or otherwise), of the information provided in this document. This
information is not to be construed as personal financial advice.
Readers are encouraged to consult their personal financial advisor
before making any decisions to buy, sell or hold any securities
mentioned herein.
NO WARRANTY OR LIABILITY ASSUMED
Analysts Review is not responsible for any error which may be
occasioned at the time of printing of this document or any error,
mistake or shortcoming. No liability is accepted by Analysts Review
whatsoever for any direct, indirect or consequential loss arising
from the use of this document. Analysts Review expressly disclaims
any fiduciary responsibility or liability for any consequences,
financial or otherwise arising from any reliance placed on the
information in this document. Analysts Review does not (1)
guarantee the accuracy, timeliness, completeness or correct
sequencing of the information, or (2) warrant any results from use
of the information. The included information is subject to change
without notice.
CFA® and Chartered Financial Analyst® are registered trademarks
owned by CFA Institute.
http://www.AnalystsReview.com/
SOURCE Analysts Review